Stock Ratings / Technology / BKYI / insiders

IFBD (38) ORKT (30) GYGY (35) LHSW (48) ⌘ Pro Terminal →

BIO-key International Inc. (BKYI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$2.93 -6.69% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.89

BIO-key International Inc. (BKYI) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $6.0M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.89 (-1.39%)🧬 Disciplined Float (+0.16% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-11.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BKYI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (33/100 Composite)

🔍 WHY BKYI SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (24% of score)

FRED Regime × Technicals: 11% of 52W Range • RSI-14 at 51.1 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.67+57.5% Next Q

Q2 (-2Q)

Grade E$2.63+28.9% Next Q

Q3 (-1Q)

Grade E$3.39-13.6% Next Q

Current

Grade E$2.93-8.9% Hist 90D α

Trajectory: E (25) → E (33)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BKYI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BKYI currently carries a cautious 33/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.58) and Max Pain ($3.08) forces dealer call-delta covering toward $14.49.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BKYI• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BKYI Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 33%NO 67%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

BKYI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (BKYI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on BKYI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BKYI)

✓Walkthrough of BKYI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BKYI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -41.28%▼ DESCENDING CHANNEL

2026-10-30O $2.90H $3.04L $2.51C $2.93VOL 296.2K

RES: $4.10SUP: $0.82SMA50: $2.58SMA200: $4.56

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BKYI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BKYI Butterfly Map → + Track BKYI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BKYI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BKYI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BKYI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BKYI)

Technology Rank #646 of 714 ⚔️ IFBD vs BKYI Full Matrix →

1. Head-to-Head Technology Peer Comparison (BKYI vs. IFBD, ORKT, GYGY, LHSW)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, BIO-key International Inc. (BKYI) ranks #646 by composite RQD confidence (33/100, grade E) and #666 by equity capitalization ($6.0M). Within this direct 5-issuer industry benchmark cohort, BKYI leads on earnings valuation at N/A trailing P/E, while BKYI leads on capital efficiency and profitability with -35.0% ROIC and 76.9% gross margin. LHSW currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with BKYI at 33/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BKYI ACTIVE BIO-key International Inc.	E	33/100	—	76.9%	-35.0%	-6.69%	$6.0M	Benchmark Subject
IFBD Infobird Co. Ltd	D-	38/100	—	29.5%	-35.0%	-7.94%	$6.1M	/ifbd-vs-bkyi →
ORKT Orangekloud Technology Inc. (Class A)	E	30/100	—	44.2%	-35.0%	-0.99%	$5.8M	/orkt-vs-bkyi →
GYGY Game Your Game Inc.	D-	35/100	—	8.6%	-35.0%	+7.59%	$5.7M	/gygy-vs-bkyi →
LHSW Lianhe Sowell International Group Ltd (Class A)	D	48/100	—	21.4%	—	+9.55%	$6.6M	/lhsw-vs-bkyi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001019034

In its most recent audited fiscal period (FY2025, filed 2025-12-31), BIO-key International Inc. (BKYI) reported GAAP revenue of $5.9M (-14.3% vs. FY2024 revenue of $6.9M ) , GAAP net income of $7.2M, operating cash flow of -$4.7M, and free cash flow of -$4.7M (-59.9% YoY). On the balance sheet, BKYI closed FY2025 with $8.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$5.9M	$7.2M	-$4.7M	-$4.7M	$8.3M	—
FY2024 (FY)	2024-12-31	$6.9M	$4.3M	-$2.9M	-$2.9M	$8.6M	$44.8K
FY2023 (FY)	2023-12-31	$0	$8.5M	-$3.8M	-$3.8M	—	—

3. BKYI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BKYI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, BIO-key International Inc. (NASDAQ: BKYI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $2.93 (-6.69% 1D, market cap $6.0M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 714 tracked Technology issuers, BKYI ranks #646 in composite RQD confidence.

How does BKYI compare to IFBD and ORKT in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, IFBD (Infobird Co. Ltd) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $6.1M) and ORKT (Orangekloud Technology Inc. (Class A)) posts a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BKYI?

Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BKYI trading relative to its 50-day, 200-day, and 52-week technical levels?

BKYI last traded at $2.93 (-6.69% on volume of 575,103 shares), positioning the stock +13.57% above its 50-day simple moving average ($2.58) and -35.75% below its 200-day simple moving average ($4.56). Across its 52-week range of $1.55 to $13.80, BKYI sits at the 11.3% percentile with a 14-day RSI of 51.1 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.56 to $3.30).

BKYI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are BKYI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies BKYI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: BKYI RQD Cockpit BKYI 12M Forecast BKYI Earnings & Move BKYI Dividends & DRIP BKYI Insiders & 13F BKYI Whale Options BKYI Profit Sankey BKYI News & Why